Username Password
S&P 500: 2,051.82
Change: -0.55%

BARD C R INC (BCR)

Overview
Price 178.20
Price Change Today -$0.39 (-0.22%)
P&P rating Rating: 1
Open Price $178.55
Previous Close $178.59
Daily Range $177.75 - $180.35
52-Week Range $125.00 - $178.99
Volume 490
chart
Top Buy Analysis
BUY: BCR Rating: 1
Company: BARD C R INC
Points: 35.82
Start Price: $88.50
Start Date: 07/11/2008 5:06 PM
LeveneOMurray
LeveneOMurray
P&P Score: 57.34
Recs:
Health Care play and therefore should still be able to rake up good earnings despite the recessionary fears and the economy slowdown.

Comments: 0 | Comment

Top Sell Analysis
SELL: BCR Rating: 1
Company: BARD C R INC
Points: -73.72
Start Price: $83.47
Start Date: 01/01/2008 12:00 AM
Happy
Happy
P&P Score: 57.00
Recs:

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

8 Buy
1 Sell
 
Free Options Trader Guide
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.99 03/21/12 Index chart Scan is implying a yellow / white flag for market 9 03/22/12
Zacks_Analysts
0.00 02/01/13 CR Bard Squarely Beats Estimates - Analyst Blog 0
Zacks_Analysts
0.00 02/01/13 CR Bard Squarely Beats Estimates - Analyst Blog 0
Zacks_Analysts
0.00 01/30/13 Earnings Preview: CR Bard Inc. - Analyst Blog 0
Zacks_Analysts
0.00 01/30/13 Earnings Preview: CR Bard Inc. - Analyst Blog 0
Zacks_Analysts
0.00 01/22/13 Teleflex Wins GPO Agreement - Analyst Blog 0
Zacks_Analysts
0.00 01/22/13 Teleflex Wins GPO Agreement - Analyst Blog 0
Zacks_Analysts
0.00 01/22/13 Covidien Wins FDA Approval - Analyst Blog 0
Zacks_Analysts
0.00 01/22/13 Covidien Wins FDA Approval - Analyst Blog 0
Zacks_Analysts
0.00 01/15/13 Covidien Begins SWIFT PRIME Study - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  27  >>
Commentary
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $72.41
Points: +19.98
Created: 05/07/2009
-8.11% per month

Comments: 0 | Comment

Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $80.25
Points: -14.17
Created: 12/13/2008
always trending well

Comments: 0 | Comment

Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $88.50
Points: +35.82
Created: 07/11/2008
Health Care play and therefore should still be able to rake up good earnings despite the recessionary fears and the economy slowdown.

Comments: 0 | Comment

Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $88.89
Points: +38.13
Created: 11/11/2011

Comments: 0 | Comment

vip vip
Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $79.41
Points: +9.57
Created: 10/21/2008

Comments: 0 | Comment

Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $96.72
Points: +32.76
Created: 04/09/2008

Comments: 0 | Comment

Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $67.10
Points: +125.80
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: BARD C R INC (BCR) Rating: 1
Start Price: $68.90
Points: +118.86
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
SELL: BARD C R INC (BCR) Rating: 1
Start Price: $83.47
Points: -73.72
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
vip 0.24 BUY One to Three Months 11/11/2011 $88.89 $178.20
(-0.22%)
+100.47% +62.35% +38.13
supratrade1 0.35 BUY One to Three Months 05/07/2009 $72.41 $178.20
(-0.22%)
+146.10% +126.12% +19.98 view
tblair 42.69 BUY Three Plus Years 12/13/2008 $80.25 $178.20
(-0.22%)
+122.06% +136.23% -14.17 view
ZeroTolerance 81.08 BUY Three to Six Months 10/21/2008 $79.41 $178.20
(-0.22%)
+124.40% +114.84% +9.57
LeveneOMurray 57.34 BUY Week or Less 07/11/2008 $88.50 $178.20
(-0.22%)
+101.36% +65.54% +35.82 view
DonDinero 89.81 BUY Three to Six Months 04/09/2008 $96.72 $178.20
(-0.22%)
+84.24% +51.48% +32.76
foolish maynard 70.33 BUY Six Months to a Year 01/01/2008 $67.10 $178.20
(-0.22%)
+165.57% +39.77% +125.80
BAHLES 83.13 BUY Six Months to a Year 01/01/2008 $68.90 $178.20
(-0.22%)
+158.64% +39.77% +118.86
Happy 57.00 SELL Six Months to a Year 01/01/2008 $83.47 $178.20
(-0.22%)
+113.49% +39.77% -73.72
Sponsored Links